SC
Silvia Caluwaerts
Director Pharmacology at Precigen Actobio
View Silvia's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Director Pharmacology
Mar 2018 - Present · 6 years and 9 months
Principal Scientist
Sep 2013 - Present · 11 years and 3 months
Pharmacology Manager
Mar 2010 - Present · 14 years and 9 months
Company Details
11-50 Employees
Precigen ActoBio™ is a clinical stage biotechnology company pioneering a new class of therapeutic agents created on the ActoBiotics™ platform. These are targeted, microbe-based, specifically designed agents that express and locally deliver potential disease-modifying therapeutics at disease sites including the intestine, the mouth and the nasopharynx, to treat a range of disorders. We have a strong R&D pipeline and an extensive portfolio of candidates advancing toward clinical development across a number of potential indications. Precigen ActoBio™ is a wholly-owned subsidiary of Precigen. More about Precigen ActoBio: https://precigen.com/companies/precigen-actobio/ More about Precigen: https://precigen.com/ For inquiries please contact: abt.info@actobio.com
Year Founded
2006
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Industriepark Zwijnaarde 7C Ghent, Flemish Region 9052, BE
Keywords
therapiestreatment applicationstargeted therapyVIBhealthcareimmunotherapytype 1 diabetesceliac diseaseimmunooncology
Discover More About Cleveland Clinic

Find verified contacts of Silvia Caluwaerts in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.